China Botanic Pharmaceutical (CBP) Reports Q3 Earnings of $0.07; Affirms Outlook
Tweet Send to a FriendGet Alerts CBP Hot Sheet
Trade CBP Now!
China Botanic Pharmaceutical (NYSE: CBP) reported Q3 EPS of $0.07, versus $0.04 reported last year. Revenue for the quarter came in at $12.4 million, versus $9.3 million reported last year.
Affirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Affirms outlook.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Gap, Inc. (GPS) Tops Q1 EPS by 2c; Reaffirms Outlook
- Hibbett Sports, Inc. (HIBB) Misses Q1 EPS by 7c; Maintains FY Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

